Log In
Register
Facebook icon
LinkedIn icon
Instagram icon
Cosmetic Ingredients
Formulas/Products
Research
Regulations
Testing
News
Leaders
Multimedia
Calendar
Home
Search
Search Cosmetics & Toiletries: Page 5
Article
Company
Document
Event
News
Podcast
Video
Webcast
Cosmetic Ingredients
Formulas/Products
Multimedia
News
Regulations
Regional
Research
Testing
Enter search phrase
Search
1,046 Results
Section: Regulations > Regional
Regional
China Revises Cosmetic Sampling Testing Rules, Calls for Comments
The measures will focus on testing in children’s cosmetics, special cosmetics and cosmetics containing new ingredients. Measures are open to public comment through July 14, 2022.
Hair Care
FDA Approves First Systemic Alopecia Areata Treatment
Olumiant is a Janus kinase (JAK) inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation to thereby treat patients with alopecia areata.
Regional
US Senate Bill to Strengthen Cosmetic Oversight Advances
Among other changes, the bill would make the FDA's Voluntary Cosmetic Registration Program mandatory.
Magazine
European Regulatory Update: UK and EU Ingredient Management
The UK and EU have made robust regulatory changes due to recently trending ingredient concerns. Updated guidances for lilial, DHA and cyclic silicones are outlined here, along with other regional updates.
Companies
The Estée Lauder Companies' Virtual Try-on Targeted by Lawsuit
Plaintiffs allege that The Estée Lauder Companies, Inc. engaged in "undisclosed collection of consumers’ biometric facial scans in Illinois."
Regional
Senate Considers FDA Fee Reauthorization Approach to Cosmetic Oversight
Senate members will present a draft legislation to reform the U.S. Food and Drug Administration's (FDA's) oversight of cosmetics, supplements and some lab-based tests based on a fee reauthorization approach, STAT reports.
Magazine
Asia-Pacific Regulatory Update: GMPs, Safety, Ingredient Restrictions, Claims and More
As the first quarter of 2022 came to a close, several regulatory changes were announced in the Asia-Pacific region. Following is an overview, which includes ingredient restrictions, claims guidelines, adverse reactions and more.
Regional
FDA Flags 12 Companies for Illicit Hydroquinone-containing Skin Brighteners
The products contain the active drug hydroquinone, rendering them unapproved over-the-counter (OTC) drugs rather than cosmetics.
Regional
China Drafts 2022 Safety and Technical Standard for Cosmetics
This draft will supersede the 2015 edition, which includes the overarching technical standards for cosmetics safety supervision and testing in China. Public comments will be accepted through April 30, 2022.
Magazine
Sunscreens and Pipe Dreams for their Regulation in the US
Initially designated as drugs in the U.S., sunscreens have been stifled under regulations and bureaucracy. This article reviews how it came to this, where current regulations stand and proposes a few “pipe dream” solutions.
Safety
Health Canada Recalls Bioderma Micellar Water, Brut Deo, Equate Oral Rinse
In recent months, Health Canada has recalled Bioderma Sensibio H2O Micellar Water and Equate Dry Mouth Oral Rinse due to microbial contamination. Also, Unilever's Brut Classic Aerosol Spray deodorant was recalled for potential benzene content.
Regional
FDA Flags Color Additive, SPF and Contaminant Offenses, Urges 'Recall Readiness'
In recent months, the U.S. Food and Drug Administration (FDA) reported six voluntary recalls for an impermissible color additive, mislabeled SPF and several contaminants. It also urged companies to be "recall ready" and provided final guidance to do so.
Safety
Consumers Alarmed Over Lilial Ban and Social Media Misdirection with Olaplex
Lilial is now classified as a carcinogenic, mutagenic or reprotoxic (CMR) Category 1B substance and is banned in the EU. In relation, Glamour recently shamed TikTok videos for misleading consumers that Olaplex No. 3 contains it and is also banned.
Magazine
European Regulatory Update: EGD, Packaging and Green Claims
In parallel with the Green Deal, the EU will outline sustainability measures and crackdown on packaging waste, plastics and green claims. This column provides an overview, along with a brief look at microbiome claims.
Regional
[updated] Hemp Act Proposes Higher THC Test Limits but Could Impact CBDs
The Hemp Advancement Act of 2022 seeks to eliminate unworkable testing requirements and set reasonable THC thresholds, according to
Forbes.
But could it impact other cannabinoids?
Magazine
Asia-Pacific Regulatory Update: Regulations Refined—GMPs, Children's Cosmetics, Animal Testing and More in China
Following previous Chinese regulatory updates, the author herein presents updated revisions from the fourth quarter of 2021. These revisions relate to cutting down excessive packaging, GMPs, monitoring adverse reactions, animal test alternatives and more.
Safety
Genistein Safe, Daidzein Inconclusive: SCCS Opinion
The European Commission's Scientific Committee on Consumer Safety (SCCS) released its opinion on the safety of genistein and daidzein in terms of potential endocrine disruption.
Regional
Hazard List, Harmonization, Toxicity Tests and O'Malley Appointment: ECHA Updates
This ECHA update includes one addition to the hazardous chemicals list, two proposals for harmonized classification/labeling (eugenol and tetrahydrofurfuryl methacrylate), advice for toxicity test dosing and the appointment of Shay O'Malley.
Previous Page
Page 5 of 59
Next Page